Pfizer Covid Vaccines Approval

US health authorities on Saturday cleared the Pfizer and Moderna Covid-19 vaccines for children aged five and younger, in a move President Joe Biden greeted as a "monumental step" in the fight against the virus.

The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.

Pfizer and BioNTech announced Tuesday they had formally asked the United States drug regulator for emergency approval of a second booster shot of their Covid vaccine for people aged 65 and older.

Pfizer and BioNTech will soon ask US regulators for emergency authorization for a Covid-19 vaccine for children aged five and under, US media reported Tuesday.

British regulators on Wednesday approved Pfizer's Covid-19 vaccine for use in children aged five to 11, as the country reported more than 100,000 new daily cases for the first time as Omicron surged.

New Zealand's health regulator Medsafe has granted provisional approval for the Pfizer Inc COVID-19 vaccine for children aged 5 to 11 years old, the health ministry said in a statement.

South Africa on Wednesday approved Pfizer's coronavirus booster shots for over-18s, as the Omicron variant dominates rising new infections.

The EU's drug regulator approved Pfizer's coronavirus jab for children aged 5 to 11 on Thursday, clearing the way for the vaccination in a cohort where the virus is rapidly spreading.

Canada on Friday became the latest country to authorize the Pfizer-BioNTech Covid-19 vaccine for children aged between five and 11-years-old, according to an official statement.

The United States can now start giving children aged 5-11 the Pfizer-BioNtech Covid vaccine, US health authorities said Tuesday as they gave final approval to this new phase of fighting the pandemic.

Pfizer-BioNTech submitted an authorization request to Health Canada on Monday for the use of its Covid-19 vaccine in children aged 5-11, the companies and the Canadian government said.

Pfizer and BioNTech said Friday they had submitted data to the EU's medicines watchdog for the approval of their coronavirus vaccine for children aged 5 to 11, following a similar step in the United States.

The EU's drug watchdog on Monday approved booster doses of the Pfizer/BioNTech Covid vaccine for all people aged 18 and over, amid concerns that protection dips after initial jabs.

A committee of US health experts on Thursday declined to approve Pfizer booster shots for individuals at high risk of Covid exposure due to their jobs, despite authorization from a different agency just the night before.

The European Union's drug watchdog said Thursday it expected to decide in early October whether to approve boosters of the Pfizer/BioNTech COVID-19 vaccine for over 16s.

US health authorities on Saturday cleared the Pfizer and Moderna Covid-19 vaccines for children aged five and younger, in a move President Joe Biden greeted as a "monumental step" in the fight against the virus.

The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.

Pfizer and BioNTech announced Tuesday they had formally asked the United States drug regulator for emergency approval of a second booster shot of their Covid vaccine for people aged 65 and older.

Pfizer and BioNTech will soon ask US regulators for emergency authorization for a Covid-19 vaccine for children aged five and under, US media reported Tuesday.

British regulators on Wednesday approved Pfizer's Covid-19 vaccine for use in children aged five to 11, as the country reported more than 100,000 new daily cases for the first time as Omicron surged.

New Zealand's health regulator Medsafe has granted provisional approval for the Pfizer Inc COVID-19 vaccine for children aged 5 to 11 years old, the health ministry said in a statement.

South Africa on Wednesday approved Pfizer's coronavirus booster shots for over-18s, as the Omicron variant dominates rising new infections.

The EU's drug regulator approved Pfizer's coronavirus jab for children aged 5 to 11 on Thursday, clearing the way for the vaccination in a cohort where the virus is rapidly spreading.

Canada on Friday became the latest country to authorize the Pfizer-BioNTech Covid-19 vaccine for children aged between five and 11-years-old, according to an official statement.

The United States can now start giving children aged 5-11 the Pfizer-BioNtech Covid vaccine, US health authorities said Tuesday as they gave final approval to this new phase of fighting the pandemic.

Pfizer-BioNTech submitted an authorization request to Health Canada on Monday for the use of its Covid-19 vaccine in children aged 5-11, the companies and the Canadian government said.

Pfizer and BioNTech said Friday they had submitted data to the EU's medicines watchdog for the approval of their coronavirus vaccine for children aged 5 to 11, following a similar step in the United States.

The EU's drug watchdog on Monday approved booster doses of the Pfizer/BioNTech Covid vaccine for all people aged 18 and over, amid concerns that protection dips after initial jabs.

A committee of US health experts on Thursday declined to approve Pfizer booster shots for individuals at high risk of Covid exposure due to their jobs, despite authorization from a different agency just the night before.

The European Union's drug watchdog said Thursday it expected to decide in early October whether to approve boosters of the Pfizer/BioNTech COVID-19 vaccine for over 16s.